TOPIK Study: A Study to Report Progressive Multifocal Leukoencephalopathy and Other Serious Opportunistic Infections in Natalizumab Treated Participants

Condition:   Multiple Sclerosis Intervention:   Drug: Natalizumab Sponsors:   Biogen;   Association for Functional Rehabilitation, Recreation and Applied Kinesiology Impulse Recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials